Advisory Committee
- Date: 2020-04-01
- Update: 2025-03-27
- Source:
- Views: 6265
October 1, 2024 - September 30, 2027
| NAME | POSITION |
|---|---|
| Deh-Ming Chang | Medical Adviser, Taipei Veterans General Hospital, Taiwan, ROC Professor Emeritus, National Defense Medical Center, Taiwan, ROC |
| Shan-Chwen Chang | Executive Vice President, National Taiwan University Professor, Department of Internal Medicine, National Taiwan University, College of Medicine Attending Physician, Department of Internal Medicine, National Taiwan University Hospital |
|
Eva Y.-H. P. Lee
|
Academician and Distinguished Visiting Chair, Genomics Research Center, Academia Sinica Chancellor's Professor, Department of Biological Chemistry University of California, Irvine, USA |
|
Cheng-Chieh Lin
|
Vice President, China Medical University Chairman, International Association of Gerontology and Geriatrics Asia/Oceania Region |
| Shio-Jea Lin | Hsu Wen-Lung Chair Professor, Chi Mei Medical System |
|
Mien-Chie Hung
|
Academician, Academia Sinica President,China Medical University |
|
Jo Shen
|
Vivo Capital, Venture Partner |
| Chin-Tay Shih | Honorary Chair, College of Technology Management, National Tsing Hua University |
|
Wei-Shiung Yang
|
Attending physician, Department of Internal Medicine, National Taiwan University Hospital Distinguished Professor, Graduate Institute of Clinical Dentistry, National Taiwan University Medical College |
| Yu-Hsin Yang | Director, Department of Social Affairs, Keelung City Government Director of the Board, Taiwan Foundation For Rare Disorders Director of Taiwan Organ Sharing Registry and Patient Autonomy Promotion Center Executive Director of Taiwan Organization for Disadvantaged Patients Honorary Consultant of the Legislative Yuan |
|
Meng-Chao Yao
|
Academician and Distinguished Research Fellow Institute of Molecular Biology, Academia Sinica |
|
Edward T.H. Yeh
|
Academician, Academia Sinica Chairman, Department of Internal Medicine, University of Arkansas for Medical Sciences, USA |
| Karen Wen | COO & Chief Strategy Officer GenomeFrontier Therapeutics, Inc. |